Shikonin inhibits the malignant progression of triple-negative breast cancer
To investigate the underlying mechanism of shikonin in TNBC, we performed high-throughput sequencing to screen differentially expressed genes 24 hours after shikonin treatment Overall design: Target genes and related regulatory pathways were identified by RNA-seq and KEGG enrichment analysis